NeurExo Sciences to Host Teach-In Featuring Michael Chopp, PhD, and Pioneering Exosome Technology in NYC February 12, 2019; Webcast Also Available; Research Indicates Exosomes Have Therapeutic Potential for Improving Recovery After Stroke, TBI

On Tueday, February 12, 2019, 8.00 am to 9.30 am EST in New York City, NeurExo Sciences (NXS), LLC, a biopharmaceutical company and subsidiary of NeuroTrauma Sciences, LLC, will be hosting a teach-in event “Enriched Exosomes, a Novel Therapeutic Approach,” featuring leading exosome researcher, Michael Chopp, PhD, Vice Chairman, Department of Neurology and Scientific Director, Neurosciences Institute, Zoltan J. Kovacs Chair of Neuroscience Research at Henry Ford Health System (HFHS), Detroit, and Distinguished Professor of Physics, Oakland University (MI). The teach-in will take place at the New York Marriott Marquis, Manhattan Ballroom, 8th floor, 1535 Broadway, New York 10036, with breakfast opening at 7.30 am. This event is intended for institutional investors, sell-side analysts, investment bankers, and business development professionals. Please RSVP in advance if you are interested in attending, as space is limited. You may RSVP with Susan Pietropaolo at 201-923-2049 (susan@smpcommunications/20190212). The teach-in will also be webcast ( and registration for the webcast is now open. The live webcast and replay will be available through the link above or at the NeuroTrauma Sciences website, Dr. Chopp's presentation will provide a primer and overview of exosomes, small extracellular vesicles that provide a means of mediating intercellular communication. He will also focus on his team's pioneering technology employing exosomes engineered with enriched microRNA for the purpose of treating neurological disease and injury, including stroke and traumatic brain injury (TBI).
Login Or Register To Read Full Story